| Filed On | Filing |
|---|---|
| 28 Oct 2026 |
8-K: Other Events
On October 28, 2026, Genprex, Inc. (“Genprex” or the “Company”) issued a press release announcing that research conducted under its sponsored research collaboration with Meharry Medical College will be featured at the Gerontological Soci... |
| 21 Oct 2026 |
8-K: Other Events
On October 21, 2026, Genprex, Inc. (“Genprex” or the “Company”) issued a press release highlighting new peer-reviewed research in mice identifying an important role for the TUSC2 tumor suppressor gene in maintaining cellular processes as... |
| 18 Aug 2026 | 8-K: Other Events |
| 14 Aug 2026 | FORM 10-Q |
| 05 Aug 2026 | 8-K: Notice of Delisting or Failure to Satisfy a Listing Rule |
| 03 Aug 2026 | 8-K: Other Events |
| 30 Jul 2026 | 8-K: Notice of Delisting or Failure to Satisfy a Listing Rule; Other Events |
| 14 Jul 2026 | 8-K: Material Modification to Rights of Security Holders; Amendments to Articles/Bylaws; Change in Fiscal Year +2 more |
| 26 Jun 2026 | FORM S-8 |
| 22 Jun 2026 | 8-K: Other Events |
| 18 Jun 2026 | 8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders |
| 12 Jun 2026 | 8-K: Notice of Delisting or Failure to Satisfy a Listing Rule; Other Events |
| 05 Jun 2026 | FORM S-3 |
| 26 May 2026 | 8-K: Other Events |
| 14 May 2026 | 8-K: Other Events |
| 13 May 2026 | FORM 10-Q |
| 11 May 2026 | SCHEDULE 13G/A |
| 30 Apr 2026 | 8-K: Other Events |
| 29 Apr 2026 | FORM ARS |
| 29 Apr 2026 |
Proxy statement: annual meeting on June 18, 2026
CEO pay $729K, up 35% · say-on-pay vote |
Loading...
